504 related articles for article (PubMed ID: 26362436)
1. Ruptured Tendons in Anabolic-Androgenic Steroid Users: A Cross-Sectional Cohort Study.
Kanayama G; DeLuca J; Meehan WP; Hudson JI; Isaacs S; Baggish A; Weiner R; Micheli L; Pope HG
Am J Sports Med; 2015 Nov; 43(11):2638-44. PubMed ID: 26362436
[TBL] [Abstract][Full Text] [Related]
2. The Anabolic 500 survey: characteristics of male users versus nonusers of anabolic-androgenic steroids for strength training.
Ip EJ; Barnett MJ; Tenerowicz MJ; Perry PJ
Pharmacotherapy; 2011 Aug; 31(8):757-66. PubMed ID: 21923602
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and Behaviors of Older Male Anabolic Steroid Users.
Ip EJ; Trinh K; Tenerowicz MJ; Pal J; Lindfelt TA; Perry PJ
J Pharm Pract; 2015 Oct; 28(5):450-6. PubMed ID: 24643452
[TBL] [Abstract][Full Text] [Related]
4. Psychological and physical impact of anabolic-androgenic steroid dependence.
Ip EJ; Lu DH; Barnett MJ; Tenerowicz MJ; Vo JC; Perry PJ
Pharmacotherapy; 2012 Oct; 32(10):910-9. PubMed ID: 23033230
[TBL] [Abstract][Full Text] [Related]
5. Anabolic-androgenic steroid use among Brazilian bodybuilders.
Nogueira FR; Brito Ade F; Oliveira CV; Vieira TI; Gouveia RL
Subst Use Misuse; 2014 Jul; 49(9):1138-45. PubMed ID: 24832911
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular Toxicity of Illicit Anabolic-Androgenic Steroid Use.
Baggish AL; Weiner RB; Kanayama G; Hudson JI; Lu MT; Hoffmann U; Pope HG
Circulation; 2017 May; 135(21):1991-2002. PubMed ID: 28533317
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for illicit anabolic-androgenic steroid use in male weightlifters: a cross-sectional cohort study.
Pope HG; Kanayama G; Hudson JI
Biol Psychiatry; 2012 Feb; 71(3):254-61. PubMed ID: 21839424
[TBL] [Abstract][Full Text] [Related]
8. Features of men with anabolic-androgenic steroid dependence: A comparison with nondependent AAS users and with AAS nonusers.
Kanayama G; Hudson JI; Pope HG
Drug Alcohol Depend; 2009 Jun; 102(1-3):130-7. PubMed ID: 19339124
[TBL] [Abstract][Full Text] [Related]
9. Somatic effects of AAS abuse: A 30-years follow-up study of male former power sports athletes.
Lindqvist Bagge AS; Rosén T; Fahlke C; Ehrnborg C; Eriksson BO; Moberg T; Thiblin I
J Sci Med Sport; 2017 Sep; 20(9):814-818. PubMed ID: 28389219
[TBL] [Abstract][Full Text] [Related]
10. Clustering psychopathology in male anabolic-androgenic steroid users and nonusing weightlifters.
Jørstad ML; Scarth M; Torgersen S; Pope HG; Bjørnebekk A
Brain Behav; 2023 Jul; 13(7):e3040. PubMed ID: 37150843
[TBL] [Abstract][Full Text] [Related]
11. Body image and attitudes toward male roles in anabolic-androgenic steroid users.
Kanayama G; Barry S; Hudson JI; Pope HG
Am J Psychiatry; 2006 Apr; 163(4):697-703. PubMed ID: 16585446
[TBL] [Abstract][Full Text] [Related]
12. Cognitive deficits in long-term anabolic-androgenic steroid users.
Kanayama G; Kean J; Hudson JI; Pope HG
Drug Alcohol Depend; 2013 Jun; 130(1-3):208-14. PubMed ID: 23253252
[TBL] [Abstract][Full Text] [Related]
13. Anabolic androgenic steroids--use and correlates among gym users--an assessment study using questionnaires and observations at gyms in the Stockholm region.
Leifman H; Rehnman C; Sjöblom E; Holgersson S
Int J Environ Res Public Health; 2011 Jul; 8(7):2656-74. PubMed ID: 21845151
[TBL] [Abstract][Full Text] [Related]
14. Use of fluroquinolone and risk of Achilles tendon rupture: a population-based cohort study.
Sode J; Obel N; Hallas J; Lassen A
Eur J Clin Pharmacol; 2007 May; 63(5):499-503. PubMed ID: 17334751
[TBL] [Abstract][Full Text] [Related]
15. Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem.
Kanayama G; Hudson JI; DeLuca J; Isaacs S; Baggish A; Weiner R; Bhasin S; Pope HG
Addiction; 2015 May; 110(5):823-31. PubMed ID: 25598171
[TBL] [Abstract][Full Text] [Related]
16. Long-term anabolic steroids in male bodybuilders induce cardiovascular structural and autonomic abnormalities.
Barbosa Neto O; da Mota GR; De Sordi CC; Resende EAMR; Resende LAPR; Vieira da Silva MA; Marocolo M; Côrtes RS; de Oliveira LF; Dias da Silva VJ
Clin Auton Res; 2018 Apr; 28(2):231-244. PubMed ID: 29019018
[TBL] [Abstract][Full Text] [Related]
17. Severe biventricular cardiomyopathy in both current and former long-term users of anabolic-androgenic steroids.
Abdullah R; Bjørnebekk A; Hauger LE; Hullstein IR; Edvardsen T; Haugaa KH; Almaas VM
Eur J Prev Cardiol; 2024 Mar; 31(5):599-608. PubMed ID: 37992194
[TBL] [Abstract][Full Text] [Related]
18. Ultrastructural analysis of ruptured tendon from anabolic steroid users.
Evans NA; Bowrey DJ; Newman GR
Injury; 1998 Dec; 29(10):769-73. PubMed ID: 10341901
[TBL] [Abstract][Full Text] [Related]
19. Anabolic androgenic steroids in the general population: user characteristics and associations with substance use.
Hakansson A; Mickelsson K; Wallin C; Berglund M
Eur Addict Res; 2012; 18(2):83-90. PubMed ID: 22286840
[TBL] [Abstract][Full Text] [Related]
20. The Effect of Chronic Anabolic-Androgenic Steroid Use on Tp-E Interval, Tp-E/Qt Ratio, and Tp-E/Qtc Ratio in Male Bodybuilders.
Alizade E; Avcı A; Fidan S; Tabakçı M; Bulut M; Zehir R; Simsek Z; Evlice M; Arslantaş U; Çakır H; Emiroglu MY; Akçakoyun M
Ann Noninvasive Electrocardiol; 2015 Nov; 20(6):592-600. PubMed ID: 25631523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
